ProKidney Corp. Payments to Acquire Marketable Securities
ProKidney Corp. (PROK) reported Payments to Acquire Marketable Securities of $76.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-10
- ProKidney Corp. payments to acquire marketable securities for the quarter ending 2026-06-30 was $32.03M, a 24.96% decline year-over-year.
- ProKidney Corp. payments to acquire marketable securities for the quarter ending 2026-03-31 was $44.75M, a 19.29% decline year-over-year.
- ProKidney Corp. payments to acquire marketable securities for the quarter ending 2025-12-31 was $40.40M, a 13.55% decline year-over-year.
- ProKidney Corp. payments to acquire marketable securities for the quarter ending 2025-09-30 was $78.54M, a 59.60% decline year-over-year.
- ProKidney Corp. payments to acquire marketable securities for fiscal 2025 was $217.08M, a 33.01% decline from fiscal 2024.
- ProKidney Corp. payments to acquire marketable securities for fiscal 2024 was $324.02M, a 31.29% decline from fiscal 2023.
- ProKidney Corp. payments to acquire marketable securities for fiscal 2023 was $471.60M.
- ProKidney Corp. payments to acquire marketable securities for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $32.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $76.79M 10-Q · filed 2026-08-10 | $117.19M derived: sum of 3 quarters · filed 2026-08-10 | $195.73M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $44.75M 10-Q · filed 2026-05-15 | $85.15M derived: sum of 2 quarters · filed 2026-05-15 | $163.69M derived: sum of 3 quarters · filed 2026-05-15 | $206.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $40.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $118.94M derived: sum of 2 quarters · filed 2026-03-18 | $161.63M derived: sum of 3 quarters · filed 2026-08-10 | $217.08M 10-K · filed 2026-03-18 |
| 2025-09-30 | $78.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $121.23M derived: sum of 2 quarters · filed 2026-08-10 | $176.68M 10-Q · filed 2025-11-10 | $223.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $42.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $98.14M 10-Q · filed 2026-08-10 | $144.87M derived: sum of 3 quarters · filed 2026-08-10 | $339.28M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $55.45M 10-Q · filed 2026-05-15 | $102.18M derived: sum of 2 quarters · filed 2026-05-15 | $296.59M derived: sum of 3 quarters · filed 2026-05-15 | $324.06M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $46.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $241.14M derived: sum of 2 quarters · filed 2026-03-18 | $268.61M derived: sum of 3 quarters · filed 2026-03-18 | $324.02M 10-K · filed 2026-03-18 |
| 2024-09-30 | $194.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $221.88M derived: sum of 2 quarters · filed 2025-11-10 | $277.29M 10-Q · filed 2025-11-10 | $447.19M derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-06-30 | $27.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $82.88M 10-Q · filed 2025-08-12 | $252.78M derived: sum of 3 quarters · filed 2026-03-18 | $292.64M derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-03-31 | $55.41M 10-Q · filed 2025-05-12 | $225.32M derived: sum of 2 quarters · filed 2026-03-18 | $265.17M derived: sum of 3 quarters · filed 2026-03-18 | $328.98M derived: sum of 4 quarters · filed 2026-03-18 |
| 2023-12-31 | $169.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $209.76M derived: sum of 2 quarters · filed 2026-03-18 | $273.57M derived: sum of 3 quarters · filed 2026-03-18 | $471.60M 10-K · filed 2026-03-18 |
| 2023-09-30 | $39.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $103.66M derived: sum of 2 quarters · filed 2024-11-12 | $301.70M 10-Q · filed 2024-11-12 | $301.70M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $63.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $261.85M 10-Q · filed 2024-08-09 | $261.85M derived: sum of 3 quarters · filed 2025-03-17 | $261.85M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $198.04M 10-Q · filed 2024-05-10 | $198.04M derived: sum of 2 quarters · filed 2025-03-17 | $198.04M derived: sum of 3 quarters · filed 2025-03-17 | $198.04M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 derived: sum of 3 quarters · filed 2025-03-17 | $0.00 10-K · filed 2025-03-17 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-22 |